Regent Investment Management LLC reduced its position in UnitedHealth Group Inc (NYSE:UNH) by 1.4% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 12,787 shares of the healthcare conglomerate’s stock after selling 175 shares during the period. Regent Investment Management LLC’s holdings in UnitedHealth Group were worth $2,779,000 at the end of the most recent quarter.
Other large investors have also recently added to or reduced their stakes in the company. North Star Investment Management Corp. acquired a new stake in UnitedHealth Group in the 3rd quarter worth approximately $30,000. Massey Quick Simon & CO. LLC boosted its stake in UnitedHealth Group by 212.5% in the 3rd quarter. Massey Quick Simon & CO. LLC now owns 175 shares of the healthcare conglomerate’s stock worth $38,000 after purchasing an additional 119 shares in the last quarter. Griffin Asset Management Inc. acquired a new stake in UnitedHealth Group in the 2nd quarter worth approximately $44,000. Coastal Capital Group Inc. acquired a new stake in UnitedHealth Group in the 2nd quarter worth approximately $45,000. Finally, Capital Advisors Ltd. LLC boosted its stake in UnitedHealth Group by 235.7% in the 2nd quarter. Capital Advisors Ltd. LLC now owns 235 shares of the healthcare conglomerate’s stock worth $57,000 after purchasing an additional 165 shares in the last quarter. Institutional investors and hedge funds own 85.71% of the company’s stock.
UNH traded up $0.96 during trading on Friday, reaching $244.63. 2,552,507 shares of the company’s stock were exchanged, compared to its average volume of 5,304,409. UnitedHealth Group Inc has a 1 year low of $208.07 and a 1 year high of $287.94. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.70 and a quick ratio of 0.67. The stock has a market capitalization of $226.11 billion, a P/E ratio of 18.99, a price-to-earnings-growth ratio of 1.26 and a beta of 0.60. The company’s fifty day simple moving average is $227.10 and its 200-day simple moving average is $239.65.
The company also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were issued a dividend of $1.08 per share. This represents a $4.32 annualized dividend and a dividend yield of 1.77%. The ex-dividend date of this dividend was Friday, September 13th. UnitedHealth Group’s dividend payout ratio (DPR) is 33.54%.
A number of research firms recently commented on UNH. Cantor Fitzgerald set a $310.00 target price on shares of UnitedHealth Group and gave the stock a “buy” rating in a research note on Tuesday. Royal Bank of Canada set a $311.00 price target on shares of UnitedHealth Group and gave the stock a “buy” rating in a research report on Friday, July 19th. Citigroup reduced their price target on shares of UnitedHealth Group from $299.00 to $286.00 and set a “buy” rating for the company in a research report on Wednesday. ValuEngine raised shares of UnitedHealth Group from a “sell” rating to a “hold” rating in a research report on Wednesday, October 2nd. Finally, Credit Suisse Group set a $293.00 price target on shares of UnitedHealth Group and gave the stock a “buy” rating in a research report on Thursday, August 29th. Five investment analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $283.84.
In other news, Director Richard T. Burke sold 2,000 shares of UnitedHealth Group stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $231.50, for a total transaction of $463,000.00. Following the completion of the transaction, the director now directly owns 187,979 shares of the company’s stock, valued at approximately $43,517,138.50. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director William C. Ballard, Jr. sold 12,000 shares of UnitedHealth Group stock in a transaction that occurred on Tuesday, July 23rd. The shares were sold at an average price of $255.31, for a total transaction of $3,063,720.00. Following the transaction, the director now directly owns 61,309 shares of the company’s stock, valued at $15,652,800.79. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 24,000 shares of company stock valued at $5,924,120. Insiders own 0.87% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Story: Penny Stocks
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.